Fusobacterium nucleatum regulates SLC7A11, inhibits ferroptosis and leads to oxaliplatin resistance in colorectal cancer
Fusobacterium nucleatum ( F. nucleatum ), a pathogenic bacterium associated with colorectal cancer (CRC), has been increasingly linked to chemoresistance. While ferroptosis is recognized as a contributor to chemotherapy resistance mechanisms, the regulatory role of gut microbiota in this process remains poorly...